Back
Top 4%
23.3%
Top 51%
12.4%
#1
11.5%
Top 0.9%
6.7%
Top 2%
4.0%
Top 79%
2.0%
Top 2%
2.0%
Top 12%
1.6%
Top 0.7%
1.6%
Top 0.8%
1.6%
Top 22%
1.4%
Top 2%
1.4%
Top 2%
1.2%
Top 26%
1.2%
Top 38%
1.2%
Top 3%
1.2%
Top 15%
1.2%
Top 15%
1.0%
Top 8%
1.0%
Top 53%
1.0%
Top 7%
0.7%
Top 25%
0.7%
Top 19%
0.7%
Preferences for benefit and harm outcomes of GLP-1 receptor agonists in adults with overweight or obesity: a multinational best-worst scaling study
2025-12-16
health economics
Title + abstract only
View on medRxiv
Show abstract
AimsWe aimed to elicit preferences for weight and harm outcomes of glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment. We examined heterogeneity across key patient subgroups to support tailored treatment decisions to identify patients most likely to benefit with minimal risks. Material and MethodsWe conducted a best-worst scaling survey of adults with overweight or obesity in 15 European countries, assessing 21 GLP-1 RA outcomesincluding 5% and 10% weight gain (to align with harms) a...
Predicted journal destinations
1
BMJ Open
553 training papers
2
PLOS ONE
1737 training papers
3
PLOS Medicine
95 training papers
4
BMC Medicine
155 training papers
5
Proceedings of the National Academy of Sciences
100 training papers
6
Scientific Reports
701 training papers
7
BMC Health Services Research
43 training papers
8
JAMA Network Open
125 training papers
9
International Journal of Obesity
17 training papers
10
eClinicalMedicine
55 training papers
11
BMC Public Health
148 training papers
12
Frontiers in Endocrinology
20 training papers
13
Public Health
34 training papers
14
PLOS Global Public Health
287 training papers
15
eLife
262 training papers
16
Nutrients
43 training papers
17
npj Digital Medicine
85 training papers
18
Journal of Medical Internet Research
81 training papers
19
Vaccine
140 training papers
20
Nature Communications
483 training papers
21
Genetics in Medicine
57 training papers
22
Clinical Infectious Diseases
219 training papers
23
BMJ Global Health
95 training papers